Useto navigate. Pressescto quit
Drug REMDESIVIR Molecule 3D model
Description
On October 22, 2020, FDA approved Remdesivir for use in adults & pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.
The 3D model was created on real mesh accurately (quad) Objects/geometries were named for easy finding & selecting Render was made in 3Ds Max & Vray
For printing, there are .stl & .3mf (unit in cm)
I greatly appreciate you finding & choosing my products. I am looking forward to serve you more if you advise by DM.
Thank you very much.
Drug REMDESIVIR Molecule
Royalty Free License
10% for Ukraine
Drug REMDESIVIR Molecule
Royalty Free License
10% for Ukraine
Available in these collections
- Antiviral Medicines to Covid-19 - Molecules (4 items)$32.0$29.0save 9%
3D Model formats
Format limitations
Native
- Autodesk 3ds Max (.max) (4 files)12 MBVersion: 2022Renderer: V-Ray 5Version: 2020Renderer: V-Ray 5Version: 2021Renderer: V-Ray 5Version: 2019Renderer: V-Ray 5
Exchange
- 3D Manufacturing File (.3mf)3.45 MB
- Autodesk 3ds Max (.max) (4 files)12 MBVersion: 2022Renderer: V-Ray 5Version: 2020Renderer: V-Ray 5Version: 2021Renderer: V-Ray 5Version: 2019Renderer: V-Ray 5
- Stereolithography (.stl)4.83 MB
- Alembic (.abc)223 KB
- Autodesk FBX (.fbx)181 KB
- OBJ (.obj, .mtl)1.03 MB
- 3D Studio (.3ds)580 KB
3D Model details
- Publish date2021-12-10
- Model ID#3425319
- Animated
- Rigged
- VR / AR / Low-poly
- PBR
- Geometry Polygon mesh
- Polygons 59,296
- Vertices 45,258
- Textures
- Materials
- UV Mapping
- Unwrapped UVs Unknown
- Plugins used
- Ready for 3D Printing
Similar Models
to Drug REMDESIVIR Molecule
